Immunic, Inc.
DE ˙ DB
16,63 € ↓ -16,55 (-49,87%)
2019-04-18
DEL PRIS
SecurityDE:10V / Immunic, Inc.
InstitutionRenaissance Technologies Llc
ManagerJames Simons
Latest Disclosed Ownership919,164 shares
Latest Disclosed Value $ 1,020,272
Renaissance Technologies Llc ownership in 10V / Immunic, Inc.

On May 14, 2026 - Renaissance Technologies Llc filed a 13F-HR form disclosing ownership of 919,164 shares of Immunic, Inc. (DE:10V) valued at $1,020,272 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 0 shares of Immunic, Inc.. The current value of the position is $15,287,536 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F IMMUNIC COM 4525EP101 919,164 919,164 1,020 0.0016
2026-02-12 2025-12-31 13F IMMUNIC COM 4525EP101 0 -391,653 -100.00 0 -100.00
2025-11-13 2025-09-30 13F IMMUNIC COM 4525EP101 391,653 259,499 196.36 345 275.00 0.0005
2025-08-13 2025-06-30 13F IMMUNIC COM 4525EP101 132,154 -537,310 -80.26 92 -87.38 0.0001
2025-05-14 2025-03-31 13F IMMUNIC COM 4525EP101 669,464 102,841 18.15 730 28.80 0.0011
2025-02-13 2024-12-31 13F IMMUNIC COM 4525EP101 566,623 177,542 45.63 567 -11.70 0.0008
2024-11-13 2024-09-30 13F IMMUNIC COM 4525EP101 389,081 97,994 33.66 642 98.45 0.0010
2024-08-09 2024-06-30 13F IMMUNIC COM 4525EP101 291,087 -456,184 -61.05 323 0.0005
2024-05-13 2024-03-31 13F IMMUNIC COM 4525EP101 747,271 672,465 898.95 1 0.0015
2024-02-13 2023-12-31 13F IMMUNIC COM 4525EP101 74,806 -502,594 -87.04 0 0.0002
2023-11-14 2023-09-30 13F IMMUNIC COM 4525EP101 577,400 422,500 272.76 1 0.0014
2023-08-11 2023-06-30 13F IMMUNIC COM 4525EP101 154,900 -222,560 -58.96 0 0.0006
2023-05-12 2023-03-31 13F IMMUNIC COM 4525EP101 377,460 377,460 1 0.0007
2023-02-13 2022-12-31 13F IMMUNIC COM 4525EP101 0 -130,665 -100.00 0 -100.00
2022-11-14 2022-09-30 13F IMMUNIC COM 4525EP101 130,665 101,465 347.48 413 308.91 0.0006
2022-08-12 2022-06-30 13F IMMUNIC COM 4525EP101 29,200 29,200 101 0.0001
2022-02-11 2021-12-31 13F IMMUNIC COM 4525EP101 0 -16,700 -100.00 0 -100.00
2021-11-12 2021-09-30 13F IMMUNIC COM 4525EP101 16,700 16,700 148 0.0002
2021-05-13 2021-03-31 13F IMMUNIC COM 4525EP101 0 -13,400 -100.00 0 -100.00
2021-02-10 2020-12-31 13F IMMUNIC COM 4525EP101 13,400 -22,000 -62.15 205 -68.80 0.0002
2020-11-13 2020-09-30 13F IMMUNIC COM 4525EP101 35,400 -124,531 -77.87 657 -66.10 0.0007
2020-08-13 2020-06-30 13F IMMUNIC COM 4525EP101 159,931 92,000 135.43 1,938 371.53 0.0017
2020-05-14 2020-03-31 13F IMMUNIC COM 4525EP101 67,931 7,300 12.04 411 -30.10 0.0004
2020-02-13 2019-12-31 13F IMMUNIC COM 4525EP101 60,631 18,602 44.26 588 40.00 0.0005
2019-11-13 2019-09-30 13F IMMUNIC COM 4525EP101 42,029 28,300 206.13 420 167.52 0.0004
2019-08-12 2019-06-30 13F IMMUNIC COM 4525EP101 13,729 1,008 7.92 157 5,133.33 0.0001
2019-05-14 2019-03-31 13F VITAL THERAPIES COM 92847R104 12,721 12,721 -7.34 3 -98.09 0.0000
2018-11-13 2018-09-30 13F VITAL THERAPIES COM 92847R104 0 -22,600 -100.00 0 -100.00
2018-08-13 2018-06-30 13F VITAL THERAPIES COM 92847R104 22,600 0 0.00 154 0.00 0.0002
2018-05-14 2018-03-31 13F VITAL THERAPIES COM 92847R104 22,600 -46,700 -67.39 154 -62.62 0.0002
2018-02-13 2017-12-31 13F VITAL THERAPIES COM 92847R104 69,300 14,900 27.39 412 49.82 0.0005
2017-11-13 2017-09-30 13F VITAL THERAPIES COM 92847R104 54,400 54,400 275 0.0003
2016-02-11 2015-12-31 13F VITAL THERAPIES COM 92847R104 0 0 0 0.0000
2015-11-12 2015-09-30 13F VITAL THERAPIES COM 92847R104 0 -17,889 -100.00 0 -100.00
2015-08-14 2015-06-30 13F VITAL THERAPIES COM 92847R104 17,889 17,889 377 0.0009
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.